AB 2565: Medi-Cal: pharmacist services: reporting.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2026-08-24
Current Status:
Failed
(2026-09-27: Vetoed by Governor.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services through fee-for-service (FFS) or managed care delivery systems. The Medi-Cal program is in part governed by, and funded pursuant to, federal Medicaid program provisions.
Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, as specified. Existing law authorizes the department to provide and administer Medi-Cal pharmacy services under a single statewide FFS delivery system, commonly known as the Medi-Cal Rx program. The department has implemented a transition of Medi-Cal pharmacy services, through Medi-Cal Rx, from managed care to FFS as a result of a 2019 executive order by the Governor.
This bill would require the department to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services, as specified. The bill would require the department to update its model evidence of coverage to explicitly include coverage of pharmacist services. The bill would also require the department to take appropriate corrective action for failure to comply with existing provisions of law relating to Medi-Cal coverage of pharmacist services or the issued guidance. The bill would authorize the department to implement, interpret, or make specific these provisions by means of all-plan letters, plan letters, or other similar instructions, without taking any further regulatory action.
Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services through fee-for-service (FFS) or managed care delivery systems. The Medi-Cal program is in part governed by, and funded pursuant to, federal Medicaid program provisions.
Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, as specified. Existing law authorizes the department to provide and administer Medi-Cal pharmacy services under a single statewide FFS delivery system, commonly known as the Medi-Cal Rx program. The department has implemented a transition of Medi-Cal pharmacy services, through Medi-Cal Rx, from managed care to FFS as a result of a 2019 executive order by the Governor.
This bill would require the department to require each Medi-Cal managed care plan to submit an annual report to the department containing information about pharmacist services that are within the jurisdiction of managed care plans and not within the jurisdiction of the FFS delivery system under the Medi-Cal Rx program.The bill would require the department to compile the information and to submit an annual consolidated report to the appropriate policy and fiscal committees of the Legislature, as specified. The bill would require the consolidated report to contain certain information relating to, among other things, implementation, compliance, service access, claims processing, oversight, and fiscal and public health impact.If the department determines that a managed care plan has failed to comply with the pharmacist services-related provisions, the bill would require the department to take appropriate corrective action, including enforcement action and the imposition of sanctions, if a pattern of noncompliance is identified.This bill would require the department to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services, as specified. The bill would require the department to update its model evidence of coverage to explicitly include coverage of pharmacist services. The bill would also require the department to take appropriate corrective action for failure to comply with existing provisions of law relating to Medi-Cal coverage of pharmacist services or the issued guidance. The bill would authorize the department to implement, interpret, or make specific these provisions by means of all-plan letters, plan letters, or other similar instructions, without taking any further regulatory action.
Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services through fee-for-service (FFS) or managed care delivery systems. The Medi-Cal program is in part governed by, and funded pursuant to, federal Medicaid program provisions.
Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, as specified. Existing law authorizes the department to provide and administer Medi-Cal pharmacy services under a single statewide FFS delivery system, commonly known as the Medi-Cal Rx program. The department has implemented a transition of Medi-Cal pharmacy services, through Medi-Cal Rx, from managed care to FFS as a result of a 2019 executive order by the Governor.
This bill would require the department to require each Medi-Cal managed care plan to submit an annual report to the department containing information about pharmacist services that are within the jurisdiction of managed care plans and not within the jurisdiction of the FFS delivery system under the Medi-Cal Rx program.
The bill would require the department to compile the information and to submit an annual consolidated report to the appropriate policy and fiscal committees of the Legislature, as specified. The bill would require the consolidated report to contain certain information relating to, among other things, implementation, compliance, service access, claims processing, oversight, and fiscal and public health impact.
If the department determines that a managed care plan has failed to comply with the pharmacist services-related provisions, the bill would require the department to take appropriate corrective action, including enforcement action and the imposition of sanctions, if a pattern of noncompliance is identified.
Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, the provisions relating to the Medi-Cal program are known as the Medi-Cal Act.This bill would make technical, nonsubstantive changes to the provision naming the Medi-Cal Act.Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, the provisions relating to the Medi-Cal program are known as the Medi-Cal Act.
This bill would make technical, nonsubstantive changes to the provision naming the Medi-Cal Act.
(a)The department shall issue guidance, including, but not limited to, an all-plan letter or similar instruction, clarifying Medi-Cal managed care plan obligations to cover pharmacist services pursuant to Section 14132.968 and applicable state plan amendments.
(b)The guidance issued pursuant to subdivision (a) shall include, at a minimum, all of the following:
(1)Requirements for coverage of pharmacist services consistent with Section 14132.968 and applicable state plan amendments.
(2)Expectations for timely and appropriate reimbursement of pharmacist services.
(3)Requirements for managed care plans to ensure accountability for coverage of pharmacist services at the delegated entity level, including independent physician associations or other subcontractors, where applicable.
(4)Requirements that coverage of pharmacist services be clearly reflected in provider manuals, billing guidance, and claims processing systems.
(c)The department shall update its model evidence of coverage to explicitly include coverage of pharmacist services described in Section 14132.968.
(d)If the department determines that a Medi-Cal managed care plan, or its delegated entity, has failed to comply with Section 14132.968, applicable state plan amendments, or departmental guidance issued pursuant to this section, the department shall take appropriate corrective action pursuant to its existing authority, including enforcement actions and the imposition of sanctions, as appropriate.
(e)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of all-plan letters, plan letters, or other similar instructions, without taking any further regulatory action.
(a)The department shall issue guidance, including, but not limited to, an all-plan letter or similar instruction, clarifying Medi-Cal managed care plan obligations to cover pharmacist services pursuant to Section 14132.968 and applicable state plan amendments.
(b)The guidance issued pursuant to subdivision (a) shall include, at a minimum, all of the following:
(1)Requirements for coverage of pharmacist services consistent with Section 14132.968 and applicable state plan amendments.
(2)Expectations for timely and appropriate reimbursement of pharmacist services.
(3)Requirements for managed care plans to ensure accountability for coverage of pharmacist services at the delegated entity level, including independent physician associations or other subcontractors, where applicable.
(4)Requirements that coverage of pharmacist services be clearly reflected in provider manuals, billing guidance, and claims processing systems.
(c)The department shall update its model evidence of coverage to explicitly include coverage of pharmacist services described in Section 14132.968.
(d)If the department determines that a Medi-Cal managed care plan, or its delegated entity, has failed to comply with Section 14132.968, applicable state plan amendments, or departmental guidance issued pursuant to this section, the department shall take appropriate corrective action pursuant to its existing authority, including enforcement actions and the imposition of sanctions, as appropriate.
(e)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of all-plan letters, plan letters, or other similar instructions, without taking any further regulatory action.
SECTION 1.Section 14132.967 is added to the Welfare and Institutions Code, immediately preceding Section 14132.968, to read:14132.967.(a)The department shall require each Medi-Cal managed care plan to submit an annual report to the department containing information about pharmacist services provided pursuant to Section 14132.968 and that are within the jurisdiction of Medi-Cal managed care plans and not within the jurisdiction of the fee-for-service delivery system under the Medi-Cal Rx program.(b)The department shall compile the information submitted pursuant to subdivision (a) and shall submit an annual consolidated report to the appropriate policy and fiscal committees of the Legislature, in accordance with Section 9795 of the Government Code, no later than March 1 of each year. The deadline for the initial consolidated report shall be March 1, 2028.(c)The consolidated report described in subdivision (b) shall contain all of the following information:(1)Implementation and compliance, including all of the following:(A)The extent to which the department has implemented Section 14132.968, including identification of any remaining implementation barriers or delays.(B)The departments compliance with State Plan Amendments 18-0039, 19-0017, and 20-0036.(C)Whether Medi-Cal managed care plans are complying with departmental guidance relating to pharmacist services, as described in subdivision (a), including any identified instances of noncompliance.(2)Access to pharmacist services, including both of the following:(A)The uniformity of beneficiary access to pharmacist services statewide, including utilization data by service type.(B)Identification of disparities in access by county, region, or underserved area, including rural, urban, and frontier communities, with data disaggregated by geography, beneficiary demographics, and managed care plan, to the extent feasible.(3)(A)Claims payment and processing, including all of the following:(i)The total number of claims submitted for pharmacist services, as described in subdivision (a), disaggregated by service type, and the number of claims paid, denied, or pending.(ii)The primary reasons for claim denials, categorized and quantified.(iii)Identification of any criteria used by the department or a managed care plan for payment or denial that are inconsistent with Section 14132.968 or with the applicable State Plan Amendments.(iv)The reimbursement rates for each pharmacist service, as described in subdivision (a), as paid by a managed care plan, including identification of any variation by plan or delegated entity.(v)Whether pharmacist services described in subdivision (a) are included in the managed care plans provider manuals, billing guidance, and encounter reporting systems.(vi)The average and median number of days from claim submission to payment or denial, disaggregated by service type and managed care plan.(B)For purposes of this section, reporting requirements shall include data from any delegated entity, independent physician association, or subcontractor responsible for claims processing, credentialing, or utilization management of pharmacist services.(4)Oversight and enforcement, including all of the following:(A)The methods used by the department to monitor managed care plan compliance with Section 14132.968.(B)Any corrective actions taken by the department pursuant to its existing authority, including the type of action and outcome.(C)The number of provider complaints received by the department relating to pharmacist services, categorized by issue type and resolution status.(5)Fiscal and public health impact, including both of the following:(A)The estimated fiscal and public health impacts of underutilization of pharmacist services under the Medi-Cal program.(B)Estimated cost savings forgone by the state resulting from underutilization of pharmacist services, including, but not limited to, tobacco cessation, hypertension management, contraception, immunizations, and other pharmacist-delivered services.(d)The consolidated report described in subdivision (b) shall be made publicly available and shall include only aggregated, deidentified data, as necessary to comply with state and federal privacy requirements.(e)If the department determines that a Medi-Cal managed care plan has failed to comply with Section 14132.968, applicable State Plan Amendments, applicable departmental guidance, or this section, the department shall take appropriate corrective action, including enforcement action and the imposition of sanctions pursuant to Section 14197.7 or any other applicable provisions, if a pattern of noncompliance is identified.(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of all-county letters, plan letters, or other similar instructions, without taking any further regulatory action.(a)The department shall require each Medi-Cal managed care plan to submit an annual report to the department containing information about pharmacist services provided pursuant to Section 14132.968 and that are within the jurisdiction of Medi-Cal managed care plans and not within the jurisdiction of the fee-for-service delivery system under the Medi-Cal Rx program.
(b)The department shall compile the information submitted pursuant to subdivision (a) and shall submit an annual consolidated report to the appropriate policy and fiscal committees of the Legislature, in accordance with Section 9795 of the Government Code, no later than March 1 of each year. The deadline for the initial consolidated report shall be March 1, 2028.
(c)The consolidated report described in subdivision (b) shall contain all of the following information:
(1)Implementation and compliance, including all of the following:
(A)The extent to which the department has implemented Section 14132.968, including identification of any remaining implementation barriers or delays.
(B)The departments compliance with State Plan Amendments 18-0039, 19-0017, and 20-0036.
(C)Whether Medi-Cal managed care plans are complying with departmental guidance relating to pharmacist services, as described in subdivision (a), including any identified instances of noncompliance.
(2)Access to pharmacist services, including both of the following:
(A)The uniformity of beneficiary access to pharmacist services statewide, including utilization data by service type.
(B)Identification of disparities in access by county, region, or underserved area, including rural, urban, and frontier communities, with data disaggregated by geography, beneficiary demographics, and managed care plan, to the extent feasible.
(3)(A)Claims payment and processing, including all of the following:
(i)The total number of claims submitted for pharmacist services, as described in subdivision (a), disaggregated by service type, and the number of claims paid, denied, or pending.
(ii)The primary reasons for claim denials, categorized and quantified.
(iii)Identification of any criteria used by the department or a managed care plan for payment or denial that are inconsistent with Section 14132.968 or with the applicable State Plan Amendments.
(iv)The reimbursement rates for each pharmacist service, as described in subdivision (a), as paid by a managed care plan, including identification of any variation by plan or delegated entity.
(v)Whether pharmacist services described in subdivision (a) are included in the managed care plans provider manuals, billing guidance, and encounter reporting systems.
(vi)The average and median number of days from claim submission to payment or denial, disaggregated by service type and managed care plan.
(B)For purposes of this section, reporting requirements shall include data from any delegated entity, independent physician association, or subcontractor responsible for claims processing, credentialing, or utilization management of pharmacist services.
(4)Oversight and enforcement, including all of the following:
(A)The methods used by the department to monitor managed care plan compliance with Section 14132.968.
(B)Any corrective actions taken by the department pursuant to its existing authority, including the type of action and outcome.
(C)The number of provider complaints received by the department relating to pharmacist services, categorized by issue type and resolution status.
(5)Fiscal and public health impact, including both of the following:
(A)The estimated fiscal and public health impacts of underutilization of pharmacist services under the Medi-Cal program.
(B)Estimated cost savings forgone by the state resulting from underutilization of pharmacist services, including, but not limited to, tobacco cessation, hypertension management, contraception, immunizations, and other pharmacist-delivered services.
(d)The consolidated report described in subdivision (b) shall be made publicly available and shall include only aggregated, deidentified data, as necessary to comply with state and federal privacy requirements.
(e)If the department determines that a Medi-Cal managed care plan has failed to comply with Section 14132.968, applicable State Plan Amendments, applicable departmental guidance, or this section, the department shall take appropriate corrective action, including enforcement action and the imposition of sanctions pursuant to Section 14197.7 or any other applicable provisions, if a pattern of noncompliance is identified.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of all-county letters, plan letters, or other similar instructions, without taking any further regulatory action.
SECTION 1.Section 14000.4 of the Welfare and Institutions Code is amended to read:14000.4.This chapter shall be known, and may be cited, as the Medi-Cal Act.This chapter shall be known known, and may be cited cited, as the Medi-Cal Act.
|
Date
|
Status
|
|---|---|
| Sep 27, 2026 | Vetoed by Governor. |
| Aug 27, 2026 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 20, 2026 | In Assembly. Ordered to Engrossing and Enrolling. |
| Aug 20, 2026 | Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0. Page 5593.). |
| Aug 20, 2026 | Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0.). |
| Aug 18, 2026 | Ordered to special consent calendar. |
| Aug 13, 2026 | Read second time. Ordered to third reading. |
| Aug 13, 2026 | From committee: Do pass. (Ayes 7. Noes 0.) (August 13). |
| Jun 15, 2026 | In committee: Referred to APPR. suspense file. |
| Jun 15, 2026 | In committee: Referred to suspense file. |
| Jun 4, 2026 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 9. Noes 0.) (June 3). Re-referred to Com. on APPR. |
| May 27, 2026 | Referred to Com. on HEALTH. |
| May 14, 2026 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 14, 2026 | Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 5056.) |
| May 14, 2026 | Read third time. Passed. Ordered to the Senate. (Ayes 77. Noes 0.) |
| May 7, 2026 | Read second time. Ordered to Consent Calendar. |
| May 6, 2026 | From committee: Do pass. To Consent Calendar. (Ayes 14. Noes 0.) (May 6). |
| Apr 27, 2026 | Re-referred to Com. on APPR. |
| Apr 23, 2026 | Read second time and amended. |
| Apr 22, 2026 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 16. Noes 0.) (April 21). |
| Mar 23, 2026 | Re-referred to Com. on HEALTH. |
| Mar 19, 2026 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Mar 19, 2026 | Referred to Com. on HEALTH. |
| Feb 21, 2026 | From printer. May be heard in committee March 23. |
| Feb 20, 2026 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 20, 2026 | Special Consent AB2565 Wallis | Senate Floor |
Passed |
|
| Aug 13, 2026 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 15, 2026 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 3, 2026 | Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar | Senate Standing Committee on Health |
Passed |
|
| May 14, 2026 | AB 2565 Wallis Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| May 6, 2026 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 21, 2026 | Do pass as amended, and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| California Access Coalition | ** Support | |
| California Association Of Medical Product Suppliers | ** Support | |
| California Pharmacists Association | ** Support | |
| California Pharmacists Association (CPA) | ** Support | |
| California Society Of Health-System Pharmacists | ** Support | |
| Equality California | ** Support |
GOVERNOR'S VETO
GV Bill Id:AB 2565
Author:(Wallis)
As Enrolled Ver:August 24, 2026
2/3 vote
SUMMARY
Requires the Department of Health Care Services (DHCS) to issue guidance clarifying Medi-Cal plans' obligation to cover pharmacist services and, if DHCS determines that a Medi-Cal plan has failed to comply with state law and guidance on pharmacist services, to take appropriate corrective action pursuant to its existing authority.
Governor's Veto Message
While I support the author's goal of ensuring our Medi-Cal managed care plans (MCPs) receive appropriate guidance and enforcement actions from DHCS when reimbursing providers for pharmacist services, guidance is already underway to address the concerns driving this legislation, making this bill unnecessary. Initial guidance was published in September 2025, and a comprehensive all-plan letter to further clarify MCP pharmacist-services responsibilities will be released in the coming months. These efforts are part of DHCS's existing responsibilities and processes, which do not require additional statutory direction.
COMMENTS
Pharmacist Services. Academic literature and pharmacy trade associations note pharmacists are among the most accessible, frequently visited and most trusted health-care professionals. This allows them to contribute to disease prevention, including through vaccination, early detection, symptoms alleviation, and chronic condition management. Pharmacists can also facilitate self-care, make referrals, and contribute to medication adherence and responsible use of medicines. During the COVID-19 pandemic, pharmacists emerged as important health care providers in many communities.
California has taken action to expand access to pharmacist services in recent years, passing laws to expand the scope of practice for pharmacists as well as to expand and facilitate reimbursement for pharmacist services through Medi-Cal and commercial health plans. Pharmacists are allowed to provide and bill for a range of services, including furnishing self-administered hormonal contraceptives, nicotine replacement products, and prescription medications not requiring a diagnosis that are recommended for international travelers. They are also allowed to deliver preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) for human immunodeficiency virus (HIV), medication therapy management (MTM), and specified vaccines. According to the California Pharmacists Association (CPA), the most direct health impacts of pharmacist services are in chronic disease management through the delivery of MTM to control hypertension, diabetes, heart failure, and asthma, which are conditions that drive a disproportionate share of preventable hospitalizations among Medi-Cal enrollees.
Medi-Cal Coverage of Pharmacy Services. Despite pharmacists' standing as highly trained health care providers and the coverage that exists "on paper" for their services, according to the author and sponsor, pharmacists face significant barriers to receiving reimbursement for services.
- Fee-for-Service Medi-Cal. In the Medi-Cal provider manual's description of coverage under fee-for-service Medi-Cal, DHCS notes it is required to establish reimbursement and policy for pharmacist services provided to a Medi-Cal recipient, including furnishing naloxone, furnishing self-administered hormonal contraception, initiating and administering immunizations, furnishing nicotine replacement therapy, furnishing HIV pre-exposure and post-exposure prophylaxis, furnishing travel medications, and MTM. DHCS states that furnishing pharmacists (the pharmacist ordering the medication) must be enrolled as an ordering, referring and prescribing provider for claims to be reimbursed. Pharmacy services must be billed by a Medi-Cal enrolled pharmacy. However, these services are not billed to Medi-Cal Rx, the state's fee-for-service pharmaceutical drug coverage program; rather, they are billed to the fee-for-service Medi-Cal program using the same claim form as a medical service.
- Medi-Cal Managed Care. Most Medi-Cal enrollees receive their health care through Medi-Cal managed care plans, and DHCS issues All-Plan Letters (APLs) to specify plans' obligations under Medi-Cal. According to DHCS APL 24-008 regarding immunization coverage, pharmacist services are on the Medi-Cal schedule of benefits together with authorization for reimbursement for these services, which includes initiating and administering immunizations, as authorized in law and regulation. DHCS states plans must provide pharmacist services as a reimbursable Medi-Cal benefit when rendered to a member in the outpatient pharmacy setting by a pharmacist who is trained and is providing the service in accordance with the Board of Pharmacy protocols. DHCS notes pharmacist services may be billed to plans on a medical claim for plan members, and that plans must reimburse pharmacy providers for rendering the specified pharmacist services in accordance with the requirements of specified law and regulation.
However, despite the policy stated in the APL, there do not appear to be specific references to coverage of pharmacist services in DHCS's master Medi-Cal managed care contract. Additionally, although some plans' Medi-Cal provider websites acknowledge coverage of pharmacist services, and plan contracts with health care providers may establish such coverage, in reviewing DHCS's Model Evidence of Coverage (EOC)/Member Handbook document and a sample of three Medi-Cal managed care plans' EOC/Member Handbooks, committee staff found none included an explanation of coverage of pharmacist services for Medi-Cal enrollees. Health plans commonly subcontract primary care services to physician groups, which may have their own protocols about how primary care is delivered. However, health plans are required to ensure their subcontractors cover legally mandated services—such as, in this case, pharmacist services. The complexity of health care delivery and the structure of plan subcontracting arrangements for primary care make it more difficult to assess compliance and ensure accountability for coverage of pharmacist services.
According to the Author
The law already requires managed care plans to cover and reimburse pharmacist services for Medi-Cal patients, but plans are not consistently paying for them and patients are not reliably getting them. The author indicates the gap between requirements and reality falls hardest on people in rural communities, underserved urban neighborhoods, and people experiencing homelessness who depend on pharmacists for chronic disease management, medication support, and preventive care.
Arguments in Support
The California Pharmacists Association (CPA) explains that although California authorized pharmacists to provide essential care, inconsistent implementation and billing hurdles have left many Medi-Cal patients without access. CPA argues that a lack of state oversight means that access to pharmacy services is inconsistent, even though it's a covered Medi-Cal benefit. CPA argues that this bill will ensure enforcement of current law and requirements. Finally, CPA notes the bill will lead to better health outcomes for Medi-Cal beneficiaries because it will make pharmacy services, which are largely preventive in nature, more accessible.
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Senate Appropriations Committee, DHCS estimates costs of $478,000 ($239,000 General Fund and $239,000 federal funds) in 2027-28 and $451,000 ($226,000 General Fund and $225,000 federal funds) ongoing thereafter for state administration.
VOTES
ASM HEALTH: 16-0-0
YES: Bonta, Chen, Addis, Aguiar-Curry, Ahrens, Caloza, Carrillo, Mark González, Johnson, Patel, Patterson, Rogers, Sanchez, Schiavo, Sharp-Collins, Stefani
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Hoover, Aguiar-Curry, Caloza, Dixon, Fong, Mark González, Krell, Pacheco, Pellerin, Sharp-Collins, Solache, Ta, Tangipa
ABS, ABST OR NV: Arambula
ASSEMBLY FLOOR: 77-0-3
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
ABS, ABST OR NV: Arambula, Flora, Celeste Rodriguez
SENATE FLOOR: 39-0-1
YES: Allen, Alvarado-Gil, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Choi, Cortese, Dahle, Durazo, Gonzalez, Grayson, Grove, Hurtado, Jones, Laird, Limón, McGuire, McNerney, Menjivar, Niello, Ochoa Bogh, Padilla, Pérez, Richardson, Rubio, Seyarto, Smallwood-Cuevas, Stern, Strickland, Umberg, Valladares, Wahab, Weber Pierson, Wiener
ABS, ABST OR NV: Reyes
UPDATED
VERSION: August 24, 2026
CONSULTANT: Lisa Murawski / HEALTH / (916) 319-2097 FN: 0004641
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | AB 2565 |
THIRD READING
Bill No: AB 2565
Author: Wallis (R)
Amended: 4/23/26 in Assembly
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 6/3/26
AYES: Weber Pierson, Valladares, Caballero, Durazo, Gonzalez, Grove, Menjivar, Padilla, Pérez
NO VOTE RECORDED: Rubio, Smallwood-Cuevas
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/13/26
AYES: Cervantes, Seyarto, Cabaldon, Dahle, Grayson, Richardson, Wahab
ASSEMBLY FLOOR: 77-0, 5/14/26 (Consent) - See last page for vote
SUBJECT: Medi-Cal: pharmacist services: reporting
SOURCE: California Pharmacists Association
DIGEST:
This bill requires the Department of Health Care Services (DHCS) to issue guidance clarifying Medi-Cal plans’ obligation to cover pharmacist services; to update its model evidence of coverage to explicitly include coverage of pharmacist services described in state law; and, if DHCS determines that a Medi-Cal plan has failed to comply with state law and guidance on pharmacist services, to take appropriate corrective action pursuant to its existing authority.
ANALYSIS:
Existing law:
- Establishes the Medi-Cal program, which is administered by DHCS, and under which qualified low-income individuals receive health care services. [Welfare and Institutions (WIC) §14000, et seq.]
- Authorizes the DHCS Director to contract, on a bid or nonbid basis, with any qualified individual, organization, or entity to provide services to, arrange for, or case manage the care of Medi-Cal beneficiaries and establishes managed care models that DHCS contracts with in each county. [WIC §14087.3, §14089, §14087.98, §14087.967, and §14087.5]
- Defines a Medi-Cal managed care plan (Medi-Cal plan) as any individual, organization, or entity that enters into a comprehensive risk contract with DHCS to provide covered full-scope health care services to enrolled Medi-Cal beneficiaries. [WIC §14184.101]
- Establishes a schedule of benefits under the Medi-Cal program, which includes benefits required under federal law and benefits provided at the state’s option, both of which are funded with federal and state dollars. [WIC §14132, et seq.]
- Establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls, that includes the following services:
- Furnishing travel medications;
- Furnishing naloxone hydrocholoride;
- Furnishing self-administered hormonal contraception;
- Initiating and administering immunizations;
- Providing tobacco cessation counseling and furnishing nicotine replacement therapy;
- Initiating and furnishing preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP); and,
- Providing medication therapy management pharmacist services in conjunction with the dispensing of qualified specialty drugs. [WIC §14132.968]
- Sets the reimbursement rate for pharmacist services, except for medication therapy management, at 85% of the fee schedule for physician services. [WIC §14132.968]
- Requires a pharmacist to be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program prior to rendering a pharmacist service that is submitted by a Medi-Cal pharmacy provider for reimbursement. [WIC §14132.968]
- Establishes requirements for Medi-Cal coverage of pharmacist medication therapy management services. [WIC §14132.969]
This bill:
- Requires DHCS to issue guidance, including, but not limited to, an all-plan letter or similar instruction, clarifying Medi-Cal plan obligations to cover pharmacist services.
- Requires the guidance to include, at a minimum, all of the following:
- Requirements for coverage of pharmacist services consistent with existing law and applicable state plan amendments;
- Expectations for timely and appropriate reimbursement of pharmacist services;
- Requirements for Medi-Cal plans to ensure accountability for coverage of pharmacist services at the delegated entity level, including independent physician associations or other subcontractors, where applicable; and,
- Requirements that coverage of pharmacist services be clearly reflected in provider manuals, billing guidance, and claims processing systems.
- Requires DHCS to update its model evidence of coverage to explicitly include coverage of pharmacist services described in existing law.
- Requires DHCS to take appropriate corrective action pursuant to its existing authority, including enforcement actions and the imposition of sanctions, if DHCS determines that a Medi-Cal plan, or its delegated entity, has failed to comply with state law, applicable state plan amendments, or DHCS guidance issued pursuant to this section.
- Authorizes DHCS to implement this bill via guidance without taking any further regulatory action.
Background
According to the author of this bill:
Access to health care should not get caught in a billing system that does not work. For many Medi-Cal patients, a local pharmacist is one of the easiest health care providers to reach. Pharmacists provide a wide range of clinical services, including medication therapy management, immunizations, naloxone, hormonal contraception, tobacco cessation counseling, and PrEP and PEP for HIV prevention. These are services the law already authorizes and funds. The problem is that pharmacists are often not getting paid when they provide them. This bill requires DHCS to issue clear guidance to Medi-Cal plans on their obligation to cover pharmacist services and to take corrective action when plans fail to comply. This is about making Medi-Cal work the way it is supposed to work for patients, pharmacists, and the communities they serve.
Pharmacist services. Pharmacists in California are authorized to initiate and furnish specified health services. SB 493 (Hernandez, Chapter 469, Statutes of 2013) expanded the scope of practice of a pharmacist to permit pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, and authorized pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions. AB 1114 (Eggman, Chapter 602, Statutes of 2016) added pharmacist services to the Medi-Cal schedule of benefits, required DHCS to establish a fee schedule for the services, and set the reimbursement rate at 85% of the fee schedule for physician services under the Medi-Cal program. AB 1114 required pharmacists to enroll as an ordering, referring, and prescribing provider prior to rendering a pharmacist service submitted to the Medi-Cal program for reimbursement, and subsequent bills authorized pharmacists to furnish PrEP and PEP and offer medication therapy management.
According to the Medi-Cal provider manual, treatment authorization requests are not required for pharmacist services, but the pharmacist must document in the medical record the minimum required elements: the regulation required questionnaire; reason for the encounter; appropriateness of therapeutic services provided; applicable test results (e.g. blood pressure, pulse); recipient’s relevant medical history; site of service; total time spent with the recipient and time spent on counseling; date, time of service, and identity of pharmacist providing the service; and, action taken as a result of the encounter.
Pharmacist services are not listed however, in the model evidence of coverage that DHCS updates whenever new Medi-Cal benefits are added through legislation or otherwise. Medi-Cal plans then take this template and modify it with plan branding, contacts, and other plan-specific information that consumers need. There is mention of pharmacist services in a recent Medi-Cal plan guidance on immunization requirements, All Plan Letter 24-008, which discusses how Medi-Cal plans must reimburse for pharmacist services when a pharmacist administers a vaccine in an outpatient pharmacy to a plan member. It also provides for reimbursement to pharmacists for vaccines administered through the Vaccines for Children program directly through Medi-Cal Rx. There do not appear to be any other regulations or guidance on Medi-Cal plan payment for pharmacist services.
Medi-Cal Rx. On January 7, 2019, Governor Newsom issued Executive Order (EO) N-01-19, which directed the state to take action to reduce the cost of prescription drugs and required DHCS to transition outpatient Medi-Cal prescription drug services from the managed care system to the fee-for-service delivery system under a single statewide system, known as Medi-Cal Rx. The Medi-Cal Rx system began operating in January of 2022. Under Medi-Cal Rx, the state’s contracted vendor, Magellan Medicaid Administration, Inc., is responsible for providing claims administration, providing utilization management, administering drug rebate services at DHCS’s direction, providing drug utilization review, and operating a call center for providers and beneficiaries. As a result, Medi-Cal plans now have more limited involvement with pharmacies and pharmacists.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee: DHCS estimates costs of $478,000 ($239,000 General Fund and $239,000 federal funds) in 2027-28 and $451,000 ($226,000 General Fund and $225,000 federal funds) ongoing thereafter for state administration.
SUPPORT: (Verified 8/13/26)
California Pharmacists Association (source)
California Access Coalition
California Association of Medical Product Suppliers
California Society of Health-System Pharmacists
Equality California
OPPOSITION: (Verified 8/13/26)
None received
ARGUMENTS IN SUPPORT: The California Pharmacists Association writes in support stating that over the past decade, the Legislature has taken important steps to expand access to care by authorizing Medi-Cal reimbursement for pharmacist-provided services, including immunizations, tobacco cessation, hormonal contraception, naloxone, travel medications, and HIV prevention and treatment services. Despite this clear statutory framework, implementation across Medi-Cal plans remains. Pharmacists continue to face significant barriers, including frequent claim denials, unclear or outdated billing guidance, restrictive contracting practices, and widely variable reimbursement rates that undermine the sustainability of providing these services. This bill addresses this gap by requiring DHCS to clearly define plan obligations and enforce compliance. By improving compliance among Medi-Cal plans and enabling patients to receive timely care at pharmacies, the state can reduce reliance on higher-cost physician visits, avoid preventable complications, and decrease unnecessary emergency or acute care utilization, ultimately maximizing value while maintaining access and quality.
ASSEMBLY FLOOR: 77-0, 5/14/26
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO VOTE RECORDED: Arambula, Flora, Celeste Rodriguez
Prepared by: Jen Flory / HEALTH / (916) 651-4111
8/14/26 14:10:51
**** END ****
SENATE COMMITTEE ON
Senator Sabrina Cervantes, Chair
2025 - 2026 Regular Session
AB 2565 (Wallis) - Medi-Cal: pharmacist services: reporting
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
AB 2565 would require the Department of Health Care Services (DHCS) to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services, as specified.
Fiscal Impact:
The DHCS estimates costs of $478,000 ($239,000 General Fund and $239,000 federal funds) in 2027-28 and $451,000 ($226,000 General Fund and $225,000 federal funds) ongoing thereafter for state administration.
Background:
State law establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls. Pharmacist services include the following:
- Furnishing travel medications;
- Furnishing naloxone hydrocholoride;
- Furnishing self-administered hormonal contraception;
- Initiating and administering immunizations;
- Providing tobacco cessation counseling and furnishing nicotine replacement therapy;
- Initiating and furnishing preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP); and,
- Providing medication therapy management pharmacist services in conjunction with the dispensing of qualified specialty drugs.
Current law requires a pharmacist to be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program prior to rendering a pharmacist service that is submitted by a Medi-Cal pharmacy provider for reimbursement. Medi-Cal coverage of pharmacist services may be provided through fee-for-service Medi-Cal or through Medi-Cal managed care plans.
Proposed Law:
Specific provisions of the bill would:
- Require DHCS to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services, as specified.
- Require DHCS to update its model evidence of coverage to explicitly include coverage of pharmacist services, as specified.
- Require that if DHCS determines that a Medi-Cal managed care plan has failed to comply with existing requirements related to coverage of pharmacist services, the department must take appropriate corrective action pursuant to its existing authority, including enforcement actions and the imposition of sanctions, as appropriate.
Related Legislation:
AB 2571 (Flora) would make changes to reimbursement policies for pharmacist services. The bill is scheduled to be heard June 15, 2026 in this committee.
-- END --
SENATE COMMITTEE ON HEALTH
Senator Akilah Weber Pierson, Chair
BILL NO: AB 2565
AUTHOR: | Wallis | ||
VERSION: | April 23, 2026 | ||
HEARING DATE: | June 3, 2026 | ||
CONSULTANT: | Jen Flory | ||
SUBJECT: Medi-Cal: pharmacist services: reporting.
SUMMARY:
Requires the Department of Health Care Services (DHCS) to issue guidance clarifying Medi-Cal plans’ obligation to cover pharmacist services; to update its model evidence of coverage to explicitly include coverage of pharmacist services described in state law; and, if DHCS determines that a Medi-Cal plan has failed to comply with state law and guidance on pharmacist services, to take appropriate corrective action pursuant to its existing authority.
Existing law:
- Establishes the Medi-Cal program, which is administered by DHCS, and under which qualified low-income individuals receive health care services. [WIC §14000, et seq.]
- Authorizes the DHCS Director to contract, on a bid or nonbid basis, with any qualified individual, organization, or entity to provide services to, arrange for, or case manage the care of Medi-Cal beneficiaries and establishes managed care models that DHCS contracts with in each county. [WIC §14087.3, §14089, §14087.98, §14087.967, and §14087.5]
- Defines a Medi-Cal managed care plan (Medi-Cal plan) as any individual, organization, or entity that enters into a comprehensive risk contract with DHCS to provide covered full-scope health care services to enrolled Medi-Cal beneficiaries. [WIC §14184.101]
- Establishes a schedule of benefits under the Medi-Cal program, which includes benefits required under federal law and benefits provided at the state’s option, both of which are funded with federal and state dollars. [WIC §14132, et seq.]
- Establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls, that includes the following services:
- Furnishing travel medications;
- Furnishing naloxone hydrocholoride;
- Furnishing self-administered hormonal contraception;
- Initiating and administering immunizations;
- Providing tobacco cessation counseling and furnishing nicotine replacement therapy;
- Initiating and furnishing preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP); and,
- Providing medication therapy management pharmacist services in conjunction with the dispensing of qualified specialty drugs. [WIC §14132.968]
- Sets the reimbursement rate for pharmacist services, except for medication therapy management, at 85% of the fee schedule for physician services. [WIC §14132.968]
- Requires a pharmacist to be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program prior to rendering a pharmacist service that is submitted by a Medi-Cal pharmacy provider for reimbursement. [WIC §14132.968]
- Establishes requirements for Medi-Cal coverage of pharmacist medication therapy management services. [WIC §14132.969]
This bill:
- Requires DHCS to issue guidance, including, but not limited to, an all-plan letter or similar instruction, clarifying Medi-Cal plan obligations to cover pharmacist services.
- Requires the guidance to include, at a minimum, all of the following:
- Requirements for coverage of pharmacist services consistent with existing law and applicable state plan amendments;
- Expectations for timely and appropriate reimbursement of pharmacist services;
- Requirements for Medi-Cal plans to ensure accountability for coverage of pharmacist services at the delegated entity level, including independent physician associations or other subcontractors, where applicable; and,
- Requirements that coverage of pharmacist services be clearly reflected in provider manuals, billing guidance, and claims processing systems.
- Requires DHCS to update its model evidence of coverage to explicitly include coverage of pharmacist services described in existing law.
- Requires DHCS to take appropriate corrective action pursuant to its existing authority, including enforcement actions and the imposition of sanctions, if DHCS determines that a Medi-Cal plan, or its delegated entity, has failed to comply with state law, applicable state plan amendments, or DHCS guidance issued pursuant to this section.
- Authorizes DHCS to implement this bill via guidance without taking any further regulatory action.
FISCAL EFFECT:
According to the Assembly Appropriations Committee, the fiscal effect of this bill is likely minor and absorbable costs to DHCS to issue clarifying guidance and update its model evidence of coverage.
PRIOR VOTES:
Assembly Floor: | 77 - 0 |
Assembly Appropriations Committee: | 14 - 0 |
Assembly Health Committee: | 16 - 0 |
COMMENTS:
- Author’s statement. According to the author, access to health care should not get caught in a billing system that does not work. For many Medi-Cal patients, a local pharmacist is one of the easiest health care providers to reach. Pharmacists provide a wide range of clinical services, including medication therapy management, immunizations, naloxone, hormonal contraception, tobacco cessation counseling, and PrEP and PEP for HIV prevention. These are services the law already authorizes and funds. The problem is that pharmacists are often not getting paid when they provide them. This bill requires DHCS to issue clear guidance to Medi-Cal plans on their obligation to cover pharmacist services and to take corrective action when plans fail to comply. This is about making Medi-Cal work the way it is supposed to work for patients, pharmacists, and the communities they serve.
- Pharmacist services. Pharmacists in California are authorized to initiate and furnish specified health services. SB 493 (Hernandez, Chapter 469, Statutes of 2013) expanded the scope of practice of a pharmacist to permit pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, and authorized pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions. AB 1114 (Eggman, Chapter 602, Statutes of 2016) added pharmacist services to the Medi-Cal schedule of benefits, required DHCS to establish a fee schedule for the services, and set the reimbursement rate at 85% of the fee schedule for physician services under the Medi-Cal program. AB 1114 required pharmacists to enroll as an ordering, referring, and prescribing provider prior to rendering a pharmacist service submitted to the Medi-Cal program for reimbursement, and subsequent bills authorized pharmacists to furnish PrEP and PEP and offer medication therapy management (see prior legislation below).
According to the Medi-Cal provider manual, treatment authorization requests are not required for pharmacist services, but the pharmacist must document in the medical record the minimum required elements: the regulation required questionnaire; reason for the encounter; appropriateness of therapeutic services provided; applicable test results (e.g. blood pressure, pulse); recipient’s relevant medical history; site of service; total time spent with the recipient and time spent on counseling; date, time of service, and identity of pharmacist providing the service; and, action taken as a result of the encounter.
Pharmacist services are not listed however, in the model evidence of coverage that DHCS updates whenever new Medi-Cal benefits are added through legislation or otherwise. Medi-Cal plans then take this template and modify it with plan branding, contacts, and other plan-specific information that consumers need. There is mention of pharmacist services in a recent Medi-Cal plan guidance on immunization requirements, All Plan Letter 24-008, which discusses how Medi-Cal plans must reimburse for pharmacist services when a pharmacist administers a vaccine in an outpatient pharmacy to a plan member. It also provides for reimbursement to pharmacists for vaccines administered through the Vaccines for Children program directly through Medi-Cal Rx. There do not appear to be any other regulations or guidance on Medi-Cal plan payment for pharmacist services.
- Medi-Cal Rx. On January 7, 2019, Governor Newsom issued EO N-01-19, which directed the state to take action to reduce the cost of prescription drugs and required DHCS to transition outpatient Medi-Cal prescription drug services from the managed care system to the fee-for-service delivery system under a single statewide system, known as Medi-Cal Rx. The Medi-Cal Rx system began operating in January of 2022. Under Medi-Cal Rx, the state’s contracted vendor, Magellan Medicaid Administration, Inc., is responsible for providing claims administration, providing utilization management, administering drug rebate services at DHCS’s direction, providing drug utilization review, and operating a call center for providers and beneficiaries. As a result, Medi-Cal plans now have more limited involvement with pharmacies and pharmacists.
- Related legislation. AB 2571 (Flora) requires DHCS to reimburse enrolled Medi-Cal pharmacists for pharmacy services; reimburse enrolled advanced practice pharmacists for medication therapy management services; and, submit a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics, as well as require a health plan or health insurer to reimburse the cost of covered services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer. AB 2571 is set for hearing on June 3, 2026 in this committee.
- Prior legislation. AB 1366 (Flora of 2025) was substantially similar to AB 2571. AB 1366 was held on the Assembly Appropriations suspense file.
AB 133 (Committee on Budget, Chapter 143, Statutes of 2021), a health trailer bill that, among other things, adds medication therapy management to the Medi-Cal schedule of benefits as a pharmacist service.
SB 159 (Wiener, Chapter 532, Statutes of 2019) adds PrEP and PEP to the list of authorized pharmacist services for health plans and health insurance and to the Medi-Cal schedule of benefits list of pharmacist services.
AB 1114 (Eggman, Chapter 602, Statutes of 2016) requires pharmacist services to be a benefit under the Medi-Cal program, establishes a list of covered pharmacist services that may be provided to a Medi-Cal beneficiary, and requires DHCS to establish a fee schedule for the list of pharmacist services to be 85% of the fee schedule for physician services under the Medi-Cal program.
SB 493 (Hernandez, Chapter 469, Statutes of 2013) expands the scope of practice of a pharmacist to recognize an advanced practice pharmacist, permits pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, and authorizes pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions.
- Support. The California Pharmacists Association writes in support stating that over the past decade, the Legislature has taken important steps to expand access to care by authorizing Medi-Cal reimbursement for pharmacist-provided services, including immunizations, tobacco cessation, hormonal contraception, naloxone, travel medications, and HIV prevention and treatment services. Despite this clear statutory framework, implementation across Medi-Cal plans remains. Pharmacists continue to face significant barriers, including frequent claim denials, unclear or outdated billing guidance, restrictive contracting practices, and widely variable reimbursement rates that undermine the sustainability of providing these services. This bill addresses this gap by requiring DHCS to clearly define plan obligations and enforce compliance. By improving compliance among Medi-Cal plans and enabling patients to receive timely care at pharmacies, the state can reduce reliance on higher-cost physician visits, avoid preventable complications, and decrease unnecessary emergency or acute care utilization, ultimately maximizing value while maintaining access and quality.
SUPPORT AND OPPOSITION:
Support: California Pharmacists Association (sponsor)
California Access Coalition
California Association of Medical Product Suppliers
Oppose: None received.
-- END --
Date of Hearing: May 6, 2026
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 2565
Author:(Wallis) – As Amended Ver:April 23, 2026
Policy Committee: | Health | Vote: | 16 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill requires the Department of Health Care Services (DHCS) to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services, as specified. The bill also requires DHCS to update its model evidence of coverage to explicitly include coverage of pharmacist services. The bill requires DHCS to take appropriate corrective action for failure to comply with existing requirements or guidance relating to Medi-Cal coverage of pharmacist services. The bill authorizes DHCS to implement, interpret, or make specific these provisions by means of all-plan letters, plan letters, or other similar instructions, without taking regulatory action.
FISCAL EFFECT:
Likely minor and absorbable costs to DHCS to issue clarifying guidance and update its model evidence of coverage.
COMMENTS:
- Purpose. This bill is sponsored by California Pharmacists Association (CPA). According to the author:
The law already requires managed care plans to cover and reimburse pharmacist services for Medi-Cal patients. But plans are not consistently paying for them, and patients are not reliably getting them. That gap falls hardest on people in rural communities, underserved urban neighborhoods, and people experiencing homelessness who depend on pharmacists for chronic disease management, medication support, and preventive care.
- Background. Pharmacist Services. In recent years, California has enacted laws to expand the scope of practice for pharmacists and expand and facilitate reimbursement for pharmacist services through Medi-Cal and commercial health plans. Pharmacists are allowed to provide and bill for a range of services, including furnishing self-administered hormonal contraceptives, nicotine replacement products, and prescription medications not requiring a diagnosis that are recommended for international travelers. They are also allowed to deliver pre- and post-exposure prophylaxis (PrEP and PEP) for HIV, medication therapy management (MTM), and specified vaccines.
Medi-Cal Coverage of Pharmacy Services. Despite pharmacists' standing as highly trained health care providers and the coverage that exists “on paper” for their services, according to the author and sponsor, pharmacists face significant barriers to receiving reimbursement for services. Most Medi-Cal enrollees receive their health care through Medi-Cal managed care plans, and DHCS issues All-Plan Letters (APLs) to specify plans’ obligations under Medi-Cal. The Assembly Health Committee analysis identified discrepancies between an APL and DHCS’s master Medi-Cal managed care contract with respect to pharmacist-provided immunization services as an example. Additionally, Assembly Health Committee staff reviewed DHCS’s Model Evidence of Coverage (EOC)/Member Handbook document and a sample of three Medi-Cal managed care plans’ EOC/Member Handbooks, and found none included an explanation of coverage of pharmacist services for Medi-Cal enrollees. Health plans commonly subcontract primary care services to physician groups, which may have their own protocols about how primary care is delivered. However, health plans are required to ensure their subcontractors cover legally mandated services—such as, in this case, pharmacist services.
This bill requires DHCS to clarify Medi-Cal managed care plan obligations and update its model EOC to explicitly include coverage of pharmacist services.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: April 21, 2026
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 2565
Author:(Wallis) – As Amended Ver:March 19, 2026
SUBJECT: Medi-Cal: pharmacist services: reporting.
SUMMARY: Requires Medi-Cal managed care plans to submit extensive data and information, and Department of Health Care Services (DHCS) to compile an annual report, on compliance with requirements to cover pharmacist services. Specifically, this bill:
- Requires DHCS to report on its compliance, and its contracting Medi-Cal managed care plans’ compliance, with law and policy governing reimbursement for pharmacist services.
- Requires the report to include, as specified:
- Utilization data;
- An access analysis and analysis of disparities by geographic area;
- The number of, and analysis of the reasons for, claims denials, by category;
- Reimbursement rates for pharmacist services;
- The results of an audit of managed care plans’ provider manuals, billing guidance, and encounter reporting systems for inclusion of pharmacist services and any criteria that are inconsistent with relevant law or policy;
- Average and median number of days for pharmacist claims to be paid;
- Descriptions of oversight and monitoring, enforcement, all corrective actions, and any provider complaints; and,
- Fiscal and public health impact of underutilization of pharmacist services under the Medi-Cal program and estimated cost savings forgone by the state resulting from underutilization of pharmacist services, including, but not limited to, tobacco cessation, hypertension management, contraception, immunizations, and other pharmacist-delivered services.
- Requires the report to include data from any delegated entity, independent physician association, or subcontractor responsible for claims processing, credentialing, or utilization management of pharmacist services.
- Requires, if DHCS determines that a Medi-Cal managed care plan has failed to comply with law or policy governing reimbursement for pharmacist services, DHCS to take appropriate corrective action, including imposing sanctions if DHCS identifies a pattern of noncompliance.
EXISTING LAW:
- Establishes the Medi-Cal program, which is administered by DHCS, and under which qualified low-income individuals receive health care services. [Welfare and Institutions Code (WIC) § 14000, et seq.]
- Establishes a schedule of benefits under the Medi-Cal program. [WIC § 14131, et seq.]
- Specifies coverage of pharmacy services under Medi-Cal, and specifies the rate of reimbursement for these services at 85% of the fee schedule for physician services under Medi-Cal. Specifies the following pharmacy services as a benefit under the Medi-Cal program, subject to federal approval, availability of federal matching funds, and DHCS protocols and utilization controls:
- Furnishing travel medications;
- Furnishing naloxone hydrochloride;
- Furnishing self-administered hormonal contraception;
- Initiating and administering immunizations;
- Providing tobacco cessation counseling and furnishing nicotine replacement therapy;
- Initiating and furnishing preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV);
- Initiating and furnishing postexposure prophylaxis (PEP) for HIV; and,
- Providing medication therapy management (MTM) pharmacist services. [WIC § 14132.968]
- Establishes requirements for Medi-Cal coverage of pharmacist MTM services. [WIC § 14132.969]
FISCAL EFFECT: Unknown. This bill has not been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, the law already requires managed care plans to cover and reimburse pharmacist services for Medi-Cal patients, but plans are not consistently paying for them and patients are not reliably getting them. The author indicates the gap between requirements and reality falls hardest on people in rural communities, underserved urban neighborhoods, and people experiencing homelessness who depend on pharmacists for chronic disease management, medication support, and preventive care. The author states this bill requires managed care plans to report annually on access, utilization, and claims, and directs the DHCS to compile that data and report to the Legislature. According to the author, this bill will ensure that noncompliant plans will be identified and held accountable, eligible patients will get the care the law already promised them, and the state will see the cost savings that comes with greater access to and utilization of pharmacist services.
- BACKGROUND.
- Pharmacist Services. Academic literature and pharmacy trade associations note pharmacists are among the most accessible, frequently visited and most trusted health-care professionals. This allows them to contribute to disease prevention, including through vaccination, early detection, symptoms alleviation, and chronic condition management. Pharmacists can also facilitate self-care, make referrals, and contribute to medication adherence and responsible use of medicines. During the COVID-19 pandemic, pharmacists emerged as important health care providers in many communities.
California has taken action to expand access to pharmacist services in recent years, passing laws to expand the scope of practice for pharmacists as well as to expand and facilitate reimbursement for pharmacist services through Medi-Cal and commercial health plans. Pharmacists are allowed to provide and bill for a range of services, including furnishing self-administered hormonal contraceptives, nicotine replacement products, and prescription medications not requiring a diagnosis that are recommended for international travelers. They are also allowed to deliver PrEP and PEP for HIV, MTM, and specified vaccines. According to the California Pharmacists Association (CPA), the most direct health impacts of pharmacist services are in chronic disease management through the delivery of MTM to control hypertension, diabetes, heart failure, and asthma, which are conditions that drive a disproportionate share of preventable hospitalizations among Medi-Cal enrollees.
- Medi-Cal Coverage of Pharmacy Services. Despite pharmacists' standing as highly trained health care providers and the coverage that exists “on paper” for their services, according to the author and sponsor, pharmacists face significant barriers to receiving reimbursement for services.
- Fee-for-Service Medi-Cal. In the Medi-Cal provider manual’s description of coverage under fee-for-service Medi-Cal, DHCS notes it is required to establish reimbursement and policy for pharmacist services provided to a Medi-Cal recipient, including furnishing naloxone, furnishing self-administered hormonal contraception, initiating and administering immunizations, furnishing nicotine replacement therapy, furnishing HIV pre-exposure and post-exposure prophylaxis, furnishing travel medications, and MTM. DHCS states that furnishing pharmacists (the pharmacist ordering the medication) must be enrolled as an ordering, referring and prescribing provider for claims to be reimbursed. Pharmacy services must be billed by a Medi-Cal enrolled pharmacy. However, these services are not billed to Medi-Cal Rx, the state’s fee-for-service pharmaceutical drug coverage program; rather, they are billed to the fee-for-service Medi-Cal program using the same claim form as a medical service.
- Medi-Cal Managed Care. Most Medi-Cal enrollees receive their health care through Medi-Cal managed care plans, and DHCS issues All-Plan Letters (APLs) to specify plans’ obligations under Medi-Cal. According to DHCS APL 24-008 regarding immunization coverage, pharmacist services are on the Medi-Cal schedule of benefits together with authorization for reimbursement for these services, which includes initiating and administering immunizations, as authorized in law and regulation. DHCS states plans must provide pharmacist services as a reimbursable Medi-Cal benefit when rendered to a member in the outpatient pharmacy setting by a pharmacist who is trained and is providing the service in accordance with the Board of Pharmacy protocols. DHCS notes pharmacist services may be billed to plans on a medical claim for plan members, and that plans must reimburse pharmacy providers for rendering the specified pharmacist services in accordance with the requirements of specified law and regulation.
- Medi-Cal Coverage of Pharmacy Services. Despite pharmacists' standing as highly trained health care providers and the coverage that exists “on paper” for their services, according to the author and sponsor, pharmacists face significant barriers to receiving reimbursement for services.
However, despite the policy stated in the APL, there do not appear to be specific references to coverage of pharmacist services in DHCS’s master Medi-Cal managed care contract. Additionally, although some plans’ Medi-Cal provider websites acknowledge coverage of pharmacist services, and plan contracts with health care providers may establish such coverage, in reviewing DHCS’s Model Evidence of Coverage (EOC)/Member Handbook document and a sample of three Medi-Cal managed care plans’ EOC/Member Handbooks, committee staff found none included an explanation of coverage of pharmacist services for Medi-Cal enrollees. Health plans commonly subcontract primary care services to physician groups, which may have their own protocols about how primary care is delivered. However, health plans are required to ensure their subcontractors cover legally mandated services—such as, in this case, pharmacist services. The complexity of health care delivery and the structure of plan subcontracting arrangements for primary care make it more difficult to assess compliance and ensure accountability for coverage of pharmacist services.
- SUPPORT. The California Pharmacists Association (CPA) explains that although California authorized pharmacists to provide essential care, inconsistent implementation and billing hurdles have left many Medi-Cal patients without access. CPA argues that a lack of state oversight means that access to pharmacy services is inconsistent, even though it’s a covered Medi-Cal benefit. CPA argues that this bill will ensure transparency and enforcement of current law and requirements, requiring annual reporting and holding plans accountable for services they are obligated to pay for under existing law and policy. Finally, CPA notes the bill will lead to better health outcomes for Medi-Cal beneficiaries because it will make pharmacy services, which are largely preventive in nature, more accessible.
- RELATED LEGISLATION. AB 2756 (Ahrens) would require DHCS to report data related to the Medi-Cal vision benefit, including utilization and information about providers, as specified. AB 2756 is pending in the Assembly Appropriations Committee.
- PREVIOUS LEGISLATION.
- SB 339 (Weiner), Chapter 1, Statutes of 2024, requires a health plan and health insurer to cover PrEP and PEP furnished by a pharmacist, including costs for the pharmacist’s services and related testing ordered by the pharmacist, and to reimburse pharmacist services at 100% of the fee schedule for physician services.
- AB 133 (Committee on Budget), Chapter 143, Statutes of 2021, requires DHCS to implement an MTM benefit and reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs.
- SB 159 (Wiener), Chapter 532, Statutes of 2019, authorizes a pharmacist to initiate and furnish HIV PrEP and PEP, as specified.
- AB 1114 (Eggman), Chapter 602, Statutes of 2016, requires specified pharmacy services to be covered under Medi-Cal, and specifies the rate of reimbursement for these services at 85% of the fee schedule for physician services under Medi-Cal.
- SB 493 (Hernandez), Chapter 469, Statutes of 2013, updates Pharmacy Law to authorize pharmacists to perform certain functions according to specified requirements and establishes advanced practice pharmacist recognition under the Board of Pharmacy.
- AMENDMENTS. Because DHCS’s APLs and model Evidence of Coverage documents do not appear to clearly describe requirements for plan coverage of pharmacist services, the author and committee have agreed to amendments to strike the reporting requirements and instead, as a first step, require DHCS to update such documents to more clearly enumerate plans’ obligations to cover such services.
REGISTERED SUPPORT / OPPOSITION:
Support
California Pharmacists Association
Opposition
None on file
Analysis Prepared by: Lisa Murawski / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):